JPH05505180A - 治療薬 - Google Patents

治療薬

Info

Publication number
JPH05505180A
JPH05505180A JP3503472A JP50347291A JPH05505180A JP H05505180 A JPH05505180 A JP H05505180A JP 3503472 A JP3503472 A JP 3503472A JP 50347291 A JP50347291 A JP 50347291A JP H05505180 A JPH05505180 A JP H05505180A
Authority
JP
Japan
Prior art keywords
group
hydrogen
formula
halo
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3503472A
Other languages
English (en)
Japanese (ja)
Inventor
ティットマン,ロジャー バーナード
ホックリィ,マイクル ヘンリィ
ギル,オンカー シング
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909002314A external-priority patent/GB9002314D0/en
Priority claimed from GB909002315A external-priority patent/GB9002315D0/en
Priority claimed from GB909002425A external-priority patent/GB9002425D0/en
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of JPH05505180A publication Critical patent/JPH05505180A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
JP3503472A 1990-02-02 1991-01-26 治療薬 Pending JPH05505180A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB909002314A GB9002314D0 (en) 1990-02-02 1990-02-02 Therapeutic agents
GB9002315.1 1990-02-02
GB909002315A GB9002315D0 (en) 1990-02-02 1990-02-02 Therapeutic agents
GB9002314.4 1990-02-02
GB909002425A GB9002425D0 (en) 1990-02-06 1990-02-06 Therapeutic agents
GB9002425.8 1990-02-06

Publications (1)

Publication Number Publication Date
JPH05505180A true JPH05505180A (ja) 1993-08-05

Family

ID=27264917

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3503472A Pending JPH05505180A (ja) 1990-02-02 1991-01-26 治療薬

Country Status (14)

Country Link
EP (1) EP0539372A1 (cs)
JP (1) JPH05505180A (cs)
KR (1) KR927003599A (cs)
AU (1) AU7220991A (cs)
BG (1) BG96715A (cs)
BR (1) BR9105984A (cs)
CA (1) CA2074841A1 (cs)
CS (1) CS23891A2 (cs)
FI (1) FI923486A0 (cs)
HU (1) HU9202510D0 (cs)
IE (1) IE910365A1 (cs)
IL (1) IL97114A0 (cs)
PT (1) PT96656A (cs)
WO (1) WO1991011448A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116241D0 (en) * 1991-07-27 1991-09-11 Boots Co Plc Therapeutic agents
CA2263586A1 (en) * 1996-09-05 1998-03-12 Eifion Phillips Novel aryl-pyridazines
SE0102404D0 (sv) * 2001-07-04 2001-07-04 Active Biotech Ab Novel immunomodulating compounds
US6642249B2 (en) 2001-07-04 2003-11-04 Active Biotech Ab Immunomodulating compounds
AU2003279687A1 (en) * 2002-11-22 2004-06-18 Active Biotech Ab Pyrazoloquinolines with immunomodulating activity
WO2004055014A1 (en) * 2002-12-16 2004-07-01 Active Biotech Ab Tetracyclic immunomodulatory compounds
CN103626787B (zh) * 2013-12-10 2016-06-15 沈阳药科大学 噻吩并硫杂类化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents

Also Published As

Publication number Publication date
CA2074841A1 (en) 1991-08-03
WO1991011448A1 (en) 1991-08-08
BR9105984A (pt) 1992-11-10
CS23891A2 (en) 1991-09-15
FI923486A7 (fi) 1992-07-31
HU9202510D0 (en) 1992-10-28
IE910365A1 (en) 1991-08-14
IL97114A0 (en) 1992-03-29
KR927003599A (ko) 1992-12-18
AU7220991A (en) 1991-08-21
PT96656A (pt) 1991-10-31
EP0539372A1 (en) 1993-05-05
FI923486A0 (fi) 1992-07-31
BG96715A (bg) 1993-12-24

Similar Documents

Publication Publication Date Title
US5475008A (en) Quinolone derivatives
WO2001064670A1 (en) Novel cyclic amide derivatives
JP2006522789A (ja) 炎症性およびアレルギー性障害の治療に有用な新規な複素環式化合物;それらの調製方法および医薬組成物
JP2000513750A (ja) ヒドラジン誘導体
JPH0278660A (ja) テトラヒドロ―1―ベンズ―[c,d]‐インドールプロピオン酸スルフオンアミド類
JP3076066B2 (ja) クロメン−3−カルボン酸誘導体
JPH10500425A (ja) 薬学的なジケトピペラジン化合物
JPS6289679A (ja) ピペリジン誘導体
JPH06135938A (ja) 3,6−ジ置換ピリダジン誘導体
JPH09501171A (ja) 5ht1d受容体アンタゴニストとしてのアミド誘導体
JP2001512727A (ja) 5ht−1受容体のリガンドとしてのニ環式化合物
JP2007513120A (ja) ピロール化合物
AU2021410119A1 (en) Tetrahydroquinoline derivative and medicinal use thereof
US4243666A (en) 4-Amino-2-piperidino-quinazolines
JPH05505180A (ja) 治療薬
JP2856548B2 (ja) チオナフタレン誘導体およびその製法並びにそれを含む抗アレルギー剤
WO2005113499A1 (ja) インドール化合物
WO2007039219A1 (en) Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor
JPS58219166A (ja) 4−キノロン誘導体
JPS60149576A (ja) 坑炎症剤として有用な置換ヒドロキシ−2,3−ジヒドロベンゾフランおよびその類似体
JPH07505394A (ja) 橋渡しビスアリールカルビノール誘導体,組成物および使用法
WO1999054303A1 (en) Optically active tetrahydrobenzindole derivatives
SA99200109B1 (ar) مشتقات إندول مفيدة، ضمن أغراض أخرى في علاج مساميه العظام
JPH08508031A (ja) 5‐ht1aリガンドとしてのアミド誘導体
JP2001511799A (ja) オキシド−スクアレンシクラーゼ阻害剤として有用なヘテロ環式化合物